FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and involves using acetylleucine or a pharmaceutically acceptable salt thereof for improving cognitive function in a subject suffering age-related cognitive decline. Age-related cognitive decline is selected from perception, memory, imaging, awareness, logical reasoning, reasoning and judgment. Subject may also exhibit gait disturbance, postural imbalance and/or spatial orientation disturbance.
EFFECT: group of inventions provides treating cognitive decline in a subject in need of improved reaction rate, vigilance or both reaction rate and vigilance, or suffers from gait disturbance, postural imbalance and/or spatial orientation disturbance.
13 cl, 6 dwg, 2 tbl, 12 ex
Authors
Dates
2025-04-02—Published
2021-03-17—Filed